Technology | 2022.03.16
KaliVir Immunotherapeutics Closes Series A Financing
--Financing Enables Company to Expedite Lead Product Candidate Toward Clinic-- PITTSBURGH, March 16, 2022 /PRNewswire/ -- KaliVir Immunotherapeutics, Inc., a privately held biotechnology company focused on the discovery and development of leading-edge oncolytic vaccinia virus...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ies-a-financing-301504135.html
